Data Collective Iv Gp is an investment fund managing more than $143 billion ran by Zachary Bogue. There are currently 6 companies in Mr. Bogue’s portfolio. The largest investments include Oklo Inc. and Recursion Pharmaceuticals, Inc., together worth $103 billion.
As of 7th August 2024, Data Collective Iv Gp’s top holding is 6,920,804 shares of Oklo Inc. currently worth over $58.6 billion and making up 41.1% of the portfolio value.
In addition, the fund holds 5,941,120 shares of Recursion Pharmaceuticals, Inc. worth $44.6 billion.
The third-largest holding is Evolv Technologies Holdings, Inc. worth $24.7 billion and the next is Rocket Lab Usa, Inc. worth $14.1 billion, with 2,929,350 shares owned.
Currently, Data Collective Iv Gp's portfolio is worth at least $143 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Data Collective Iv Gp office and employees reside in Palo Alto, California. According to the last 13-F report filed with the SEC, Zachary Bogue serves as the Managing Member at Data Collective Iv Gp.
In the most recent 13F filing, Data Collective Iv Gp revealed that it had opened a new position in Oklo Inc. and bought 6,920,804 shares worth $58.6 billion.
The two most similar investment funds to Data Collective Iv Gp are Carroll Investors, Inc and Exane Asset Management. They manage $143 billion and $143 billion respectively.
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Oklo Inc. |
Opened
6,920,804
|
$58,619,207,000 | 41.08% |
| Recursion Pharmaceuticals, Inc. |
No change
5,941,120
|
$44,558,400,000 | 31.23% |
| Evolv Technologies Holdings, Inc. |
No change
9,681,281
|
$24,687,268,000 | 17.30% |
| Rocket Lab Usa, Inc. |
No change
2,929,350
|
$14,060,880,000 | 9.85% |
| Mind Medicine (mindmed) Inc. |
No change
100,350
|
$723,523,000 | 0.51% |
| Roivant Sciences Ltd. |
No change
3,875
|
$40,959,000 | 0.03% |
| No transactions found | |||
| Showing first 500 out of 6 holdings | |||